Our observation of no association of the XPD Lys751Gln genotypes with the risk of Bladder cancer is compatible with the findings from Shen et al. [13] and Gangwar et al. [30] who reported no association of the ERCC2 codon 751 polymorphism with bladder cancer risk. Here, ERCC2 is linked to urinary bladder carcinoma.